Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.

BACKGROUND: Azathioprine (AZA) is a common immunosuppressive drug used for relapse prevention in neuromyelitis optica (NMO). OBJECTIVES: The objective of this paper is to assess efficacy, tolerability and retention of AZA in a large NMO cohort. METHODS: We conducted a retrospective review of medical...

Descripció completa

Dades bibliogràfiques
Autors principals:	Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Mutch, K, Jacob, S, Brown, R, Moss, K, McNeillis, B, Goh, Y, Leite, M, Robertson, N, Palace, J, Jacob, A
Format:	Journal article
Idioma:	English
Publicat:	SAGE Publications 2014

Ítems similars

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
per: Elsone, L, et al.
Publicat: (2013)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
per: Elsone, L, et al.
Publicat: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
per: Elsone, L, et al.
Publicat: (2012)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
per: Kitley, J, et al.
Publicat: (2012)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
per: Kitley, J, et al.
Publicat: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
per: Kitley, J, et al.
Publicat: (2013)

Seasonal pattern of variation in neuromyelitis optica relapses
per: Elsone, L, et al.
Publicat: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
per: Kitley, J, et al.
Publicat: (2013)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
per: Kitley, J, et al.
Publicat: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
per: Kitley, J, et al.
Publicat: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
per: Luppe, S, et al.
Publicat: (2012)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
per: Kitley, J, et al.
Publicat: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
per: Kitley, J, et al.
Publicat: (2014)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
per: Waters, P, et al.
Publicat: (2016)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
per: Kitley, J, et al.
Publicat: (2014)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
per: Waters, P, et al.
Publicat: (2015)

DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK
per: Kitley, J, et al.
Publicat: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
per: Collongues, N, et al.
Publicat: (2013)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
per: Kitley, J, et al.
Publicat: (2013)

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.
per: Dos Passos, GR, et al.
Publicat: (2020)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
per: Waters, P, et al.
Publicat: (2008)

Use of mitoxantrone in neuromyelitis optica.
per: Kitley, J, et al.
Publicat: (2011)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
per: Paul, F, et al.
Publicat: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
per: Friedemann Paul, et al.
Publicat: (2007-04-01)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
per: Nour, M, et al.
Publicat: (2015)

Neuromyelitis optica pathogenesis and aquaporin 4
per: Kerr Douglas, et al.
Publicat: (2008-05-01)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
per: Pittock, S, et al.
Publicat: (2019)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
per: Jarius, S, et al.
Publicat: (2008)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
per: Kitley, J, et al.
Publicat: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
per: Kitley, J, et al.
Publicat: (2014)

Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders
per: Ana Beatriz Ayroza Galvão Ribeiro GOMES, et al.
Publicat: (2021-03-01)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
per: Leite, M, et al.
Publicat: (2009)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
per: Palace, J, et al.
Publicat: (2010)

Prognostic factors in aquaporin-4 antibody-mediated disease: UK and Japanese cohorts
per: Kitley, J, et al.
Publicat: (2011)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
per: Jarius, S, et al.
Publicat: (2008)

Neuromyelitis optica
per: Jacob Anu, et al.
Publicat: (2007-01-01)

A clinical/immunological neuromyelitis optica association study
per: Kitley, J, et al.
Publicat: (2014)

Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
per: Simone Mader, et al.
Publicat: (2010-01-01)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
per: Jacob, A, et al.
Publicat: (2012)

A practical guide to the treatment of neuromyelitis optica.
per: Palace, J, et al.
Publicat: (2012)